Siegfried Priglinger, MD discussed research he presented focused on pediatric patients with inherited retinal diseases with an emphasis on studies into the RPE65 gene.
At the Envision Summit 2025 in San Juan, Puerto Rico, Nita Valikodath, MD, MS, gave insight into a challenging case of a 14-year-old boy who had trauma-related retinal detachment in his right eye, where a further macula-on retinal detachment with retinal dialysis was found in the left.
Office-based surgery could prove to be a viable option for physicians.
Nadia K. Waheed, MD, MPH, and David M. Brown, MD, discuss the future of intravitreal injections.
At ARVO 2025, in Salt Lake City, Utah, Viha Vig, talked about her poster presentation investigating the relationship between ocular and systemic mitochondrial diseases and dementia
The Virtual Eye Simulation Analyzer is an AI-driven digital twin of the human eye designed to model aging and personalize presbyopia treatment across the lifecycle.
Considerations in the treatment of diabetic retinopathy and diabetic macular edema.
Nasotemporal sagittal height asymmetry a good biomarker of shortsightednes.
Anterior segment surgeon expands on the use of the XtraFocus pinhole implant.
Several hundred genes are associated with congenital forms.
Early diagnosis of NMOSD is key to preventing disability, improving survival.
Sunita Radhakrishnan, MD, shares insights on the use of electric neurostimulation and its potential use in the treatment of glaucoma, as evidenced by its current use in Europe and the upcoming trials for use in the US.
Papilledema with back pain suggests spine lesion.
In honor of Ophthalmology Times’ 50th anniversary, anterior segment surgeons attending ASCRS 2025 weigh in on the innovations that defined modern ophthalmology.
Vizz (Lenz Therapeutics) is the first and only aceclidine-based eye drop for presbyopia and is also the first daily solution to correct vision for up to 10 hours.
Lens offering surgeons a reassuring amount of resistance to movement in the eye
Deepinder Dhaliwal, MD, LAc, explores advancements in managing Fuchs endothelial corneal dystrophy, highlighting Descemet stripping only (DSO). Long-term outcomes show promising results, supporting DSO as a viable alternative to traditional donor-tissue-based keratoplasty procedures.
Research explores innovative physiotherapeutic approaches to managing myopia progression, showing promising results in slowing its advancement over two years.
Equally important is that any symptoms of ocular allergies should be addressed to reduce the frequency of eye rubbing.
Selina McGee, OD, FAAO, emphasizes the significance of a multifactorial treatment approach for dry eye, especially in patients concurrently using other eye drops or contact lenses, and advocates for ocular sparing therapies when needed.
Adolf Fercher's 2D image of fundus paved way for today’s imaging technique.
A residency applicant shares his perspective on the pandemic’s impact.
At the Envision Summit 2025 in San Juan, Puerto Rico, Sherrol Reynolds, OD, FAAO, participated in a discussion on patient-centered care and the newest treatment strategies in neovascular AMD and DME.
The latest IOLs offer an improvement in stray light performance and enhanced contrast.
Advances enhance clinical decision-making in screening cases at risk of iatrogenic ectasia.
At ARVO 2025, in Salt Lake City, Utah, Diana Do, MD, gave an update on the LIGHTSITE III study of photobiomodulation for dry age-related macular degeneration.
Changing demographics and increasing trial complexity present challenges and opportunities.